140 related articles for article (PubMed ID: 34056907)
21. Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.
Ren S; Shao Y; Zhao X; Hong CS; Wang F; Lu X; Li J; Ye G; Yan M; Zhuang Z; Xu C; Xu G; Sun Y
Mol Cell Proteomics; 2016 Jan; 15(1):154-63. PubMed ID: 26545398
[TBL] [Abstract][Full Text] [Related]
22. The metabolomic detection of lung cancer biomarkers in sputum.
Cameron SJ; Lewis KE; Beckmann M; Allison GG; Ghosal R; Lewis PD; Mur LA
Lung Cancer; 2016 Apr; 94():88-95. PubMed ID: 26973212
[TBL] [Abstract][Full Text] [Related]
23. Serum Biomarker Panel for Rapid Early Diagnosis of Lung Cancer.
Wu S; Zhang J; Wei H; Liu Y; Dai X; Xue J; Shen T; Liu X
Curr Cancer Drug Targets; 2023; 23(7):534-546. PubMed ID: 35616661
[TBL] [Abstract][Full Text] [Related]
24. Study on potential biomarkers of energy metabolism-related to early-stage Yin-deficiency-heat syndrome based on metabolomics and transcriptomics.
Gan L; Jiang TT; Yi WJ; Lu R; Xu FY; Liu CM; Li ZB; Han YS; Hu YT; Chen J; Tu HH; Huang H; Li JC
Anat Rec (Hoboken); 2020 Aug; 303(8):2109-2120. PubMed ID: 31909898
[TBL] [Abstract][Full Text] [Related]
25. Clinical verification of plasma messenger RNA as novel noninvasive biomarker identified through bioinformatics analysis for lung cancer.
Zhou D; Tang W; Liu X; An HX; Zhang Y
Oncotarget; 2017 Jul; 8(27):43978-43989. PubMed ID: 28410204
[TBL] [Abstract][Full Text] [Related]
26. Discovery of the potential biomarkers for early diagnosis of endometrial cancer via integrating metabolomics and transcriptomics.
Fu Y; Wang C; Wu Z; Zhang X; Liu Y; Wang X; Liu F; Chen Y; Zhang Y; Zhao H; Wang Q
Comput Biol Med; 2024 May; 173():108327. PubMed ID: 38552279
[TBL] [Abstract][Full Text] [Related]
27. Metabolomics of lung cancer: Analytical platforms and their applications.
Noreldeen HAA; Liu X; Xu G
J Sep Sci; 2020 Jan; 43(1):120-133. PubMed ID: 31747121
[TBL] [Abstract][Full Text] [Related]
28. Metabolomics workflow for lung cancer: Discovery of biomarkers.
Tang Y; Li Z; Lazar L; Fang Z; Tang C; Zhao J
Clin Chim Acta; 2019 Aug; 495():436-445. PubMed ID: 31103622
[TBL] [Abstract][Full Text] [Related]
29. A comprehensive analysis of metabolomics and transcriptomics in non-small cell lung cancer.
Ruiying C; Zeyun L; Yongliang Y; Zijia Z; Ji Z; Xin T; Xiaojian Z
PLoS One; 2020; 15(5):e0232272. PubMed ID: 32374740
[TBL] [Abstract][Full Text] [Related]
30. Targeted metabolomics: Liquid chromatography coupled to mass spectrometry method development and validation for the identification and quantitation of modified nucleosides as putative cancer biomarkers.
Godoy AT; Eberlin MN; Simionato AVC
Talanta; 2020 Apr; 210():120640. PubMed ID: 31987192
[TBL] [Abstract][Full Text] [Related]
31. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
32. Probing gender-specific lipid metabolites and diagnostic biomarkers for lung cancer using Fourier transform ion cyclotron resonance mass spectrometry.
Guo Y; Wang X; Qiu L; Qin X; Liu H; Wang Y; Li F; Wang X; Chen G; Song G; Li F; Guo S; Li Z
Clin Chim Acta; 2012 Dec; 414():135-41. PubMed ID: 22906735
[TBL] [Abstract][Full Text] [Related]
33. Metabolomic profiling of human lung tumor tissues - nucleotide metabolism as a candidate for therapeutic interventions and biomarkers.
Moreno P; Jiménez-Jiménez C; Garrido-Rodríguez M; Calderón-Santiago M; Molina S; Lara-Chica M; Priego-Capote F; Salvatierra Á; Muñoz E; Calzado MA
Mol Oncol; 2018 Oct; 12(10):1778-1796. PubMed ID: 30099851
[TBL] [Abstract][Full Text] [Related]
34. Prediction of platinum-based chemotherapy efficacy in lung cancer based on LC-MS metabolomics approach.
Peng F; Liu Y; He C; Kong Y; Ouyang Q; Xie X; Liu T; Liu Z; Peng J
J Pharm Biomed Anal; 2018 May; 154():95-101. PubMed ID: 29544107
[TBL] [Abstract][Full Text] [Related]
35. Current Trends in Cancer Biomarker Discovery Using Urinary Metabolomics: Achievements and New Challenges.
Burton C; Ma Y
Curr Med Chem; 2019; 26(1):5-28. PubMed ID: 28914192
[TBL] [Abstract][Full Text] [Related]
36. Biotransformation-based metabolomics profiling method for determining and quantitating cancer-related metabolites.
Yue X; He J; Zhang R; Xu J; Zhou Z; Zhang R; Bi N; Wang Z; Sun C; Wang L; Chen Y; Abliz Z
J Chromatogr A; 2018 Dec; 1580():80-89. PubMed ID: 30473010
[TBL] [Abstract][Full Text] [Related]
37. Enhancing coverage in LC-MS-based untargeted metabolomics by a new sample preparation procedure using mixed-mode solid-phase extraction and two derivatizations.
Wu Q; Xu Y; Ji H; Wang Y; Zhang Z; Lu H
Anal Bioanal Chem; 2019 Sep; 411(23):6189-6202. PubMed ID: 31414155
[TBL] [Abstract][Full Text] [Related]
38. Serum Metabolomic Profiles for Distinguishing Lung Cancer From Pulmonary Tuberculosis: Identification of Rapid and Noninvasive Biomarker.
Chen S; Li C; Qin Z; Song L; Zhang S; Sun C; Zhuang P; Wang Y; Yang B; Ning L; Li Y
J Infect Dis; 2023 Nov; 228(9):1154-1165. PubMed ID: 37246562
[TBL] [Abstract][Full Text] [Related]
39. [A serum metabolomics study of gastric cancer based on pseudotargeted liquid chromatography-mass spectrometry approach].
Yang T; Luo P; Li Y; Hua R; Yin P; Xu G
Se Pu; 2014 Feb; 32(2):126-32. PubMed ID: 24822445
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
